Skip to main content

Animations

MJFF Publications

5631 - 5640 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2021
  • 2021
  • 2024
  • 2015
  • 2024
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
    Journal Name: Current Neuropharmacology
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/1570159x21666230801140648
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212714
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212672
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.648417
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Serotonin transporter density in isolated rapid eye movement sleep behavioral disorder
    Journal Name: Frontiers in Sleep
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/frsle.2023.1298854
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.2057
    Citation Count: 2
  • Summary Details
    OPEN
    Title: MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
    Journal Name: Aging
    Publisher: Impact Journals, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18632/aging.104200
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Investigating lymphocyte populations in patients with Parkinson’s disease
    Journal Name: Annals of Translational Medicine
    Publisher: AME Publishing Company
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.21037/atm.2020.02.29
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Flow Cytometry Measurement of Glucocerebrosidase Activity in Human Monocytes
    Journal Name: BIO-PROTOCOL
    Publisher: Bio-Protocol, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.21769/bioprotoc.3572
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.